ALISON RUBLE: Open Payments
NPI 1700288750 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,142 in 99 payments from 24 companies in 2025. Trend: 2023 $1,664 · 2024 $1,598 · 2025 $2,142
Food & beverage: $2,142
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $755 |
| ABBVIE INC. | 14 | $236 |
| GlaxoSmithKline, LLC. | 9 | $156 |
| Amgen Inc. | 18 | $140 |
| PFIZER INC. | 5 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| Lilly USA, LLC | 4 | $80 |
| Novo Nordisk Inc | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $58 |
Products named: BREZTRI, AIRSUPRA, VRAYLAR, JARDIANCE, Kerendia, TRELEGY ELLIPTA, NURTEC ODT, XIFAXAN.
Industry payments across CO — which companies pay providers there.
